Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Wistuba

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Oncotarget|July 25, 2018
LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancerLiqin Du, Zhenze Zhao, Milind Suraokar, et al.
Science Translational Medicine|June 1, 2012
Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinibBanibrata Sen, Shaohua Peng, Ximing Tang, et al.
Neoplasia (New York, N.Y.)|July 3, 2019
Corrigendum to "PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer" [<i>Neoplasia</i> 18 (2016) 282-293]Jerfiz D Constanzo, Ke-Jing Tang, Smita Rindhe, et al.
Neoplasia (New York, N.Y.)|May 31, 2016
PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung CancerJerfiz D Constanzo, Ke-Jing Tang, Smita Rindhe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancerAnne S Tsao, Xi Ming Tang, Bradley Sabloff, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 26, 2009
EphA2 in the early pathogenesis and progression of non-small cell lung cancerJennifer M Brannan, Banibrata Sen, Babita Saigal, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
A novel Bayesian model for assessing intratumor heterogeneity of tumor infiltrating leukocytes with multi-region gene expression sequencingPeng Yang, Shawna M Hubert, P Andrew Futreal, et al.
Cancer Medicine|August 29, 2019
Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancerBin Shi, Carmen Behrens, Viralkumar Vaghani, et al.
Cancer Informatics|July 18, 2018
A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous NeoplasmsSouptik Barua, Luisa Solis, Edwin Roger Parra, et al.
Nature Methods|October 27, 2022
Netie: inferring the evolution of neoantigen-T cell interactions in tumorsTianshi Lu, Seongoh Park, Yi Han, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Oncotarget|July 25, 2018
LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancerLiqin Du, Zhenze Zhao, Milind Suraokar, et al.
Science Translational Medicine|June 1, 2012
Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinibBanibrata Sen, Shaohua Peng, Ximing Tang, et al.
Neoplasia (New York, N.Y.)|July 3, 2019
Corrigendum to "PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer" [<i>Neoplasia</i> 18 (2016) 282-293]Jerfiz D Constanzo, Ke-Jing Tang, Smita Rindhe, et al.
Neoplasia (New York, N.Y.)|May 31, 2016
PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung CancerJerfiz D Constanzo, Ke-Jing Tang, Smita Rindhe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancerAnne S Tsao, Xi Ming Tang, Bradley Sabloff, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 26, 2009
EphA2 in the early pathogenesis and progression of non-small cell lung cancerJennifer M Brannan, Banibrata Sen, Babita Saigal, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
A novel Bayesian model for assessing intratumor heterogeneity of tumor infiltrating leukocytes with multi-region gene expression sequencingPeng Yang, Shawna M Hubert, P Andrew Futreal, et al.
Cancer Medicine|August 29, 2019
Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancerBin Shi, Carmen Behrens, Viralkumar Vaghani, et al.
Cancer Informatics|July 18, 2018
A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous NeoplasmsSouptik Barua, Luisa Solis, Edwin Roger Parra, et al.
Nature Methods|October 27, 2022
Netie: inferring the evolution of neoantigen-T cell interactions in tumorsTianshi Lu, Seongoh Park, Yi Han, et al.
Pageof 13